2nd Quarter - Report
INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) for INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Income
—
Expenses
$162,156
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Legislative and Regulatory Issues as they relate to compounding pharmacies: S. 959 and related bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH RYAN DODGE-PALMER | — |
| STEVE IRIZARRY | — |
| R DAVID PORE | — |
| JIM TURNER | — |
| RICH WHITE | — |
Medicare/Medicaid MMM
Reimbursement Issues related to compounded pharmacy products and third-party coverages of those products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH RYAN DODGE-PALMER | — |
Health Issues HCR
Health Care Reform Act and Health Care Issues as they Impact Compounding Pharmacists
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH RYAN DODGE-PALMER | — |
Law Enforcement/Crime/Criminal Justice LAW
DEA Issues as they relate to the Controlled Substances Act and pharmacies
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH RYAN DODGE-PALMER | — |
| R DAVID PORE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.